Dr. Erchinger studies a variety of gastrointestinal health issues, particularly focusing on conditions like pilonidal disease, which can lead to painful abscesses. He also investigates how weight loss surgery impacts the development of polyps—growths that can be precursors to colorectal cancer—in obese patients. Additionally, he examines the survival rates and treatment outcomes for different types of colon cancer, comparing medullary and nonmedullary forms to better inform treatment strategies and patient care.
Key findings
In a unique case of pilonidal disease, a patient underwent the Bascom cleft lift surgery, highlighting the need for better treatments for rare cases.
Bariatric surgery patients lost an average of 27.7% of their body weight, leading to a lower incidence of harmful polyps compared to only 3.5% weight loss in medically treated patients.
Patients with medullary colon cancer had a median survival of only 19.6 months, in stark contrast to 60.5 months for those with nonmedullary colon cancer.
Stage 3 medullary colon cancer patients experienced very poor outcomes, with an average survival of just 9.6 months, much shorter than the 47.2 months for poorly differentiated nonmedullary cases.
Frequently asked questions
Does Dr. Erchinger study pilonidal disease?
Yes, Dr. Erchinger has researched pilonidal disease, examining unusual cases and surgical treatment options.
What treatments has Dr. Erchinger researched?
He has focused on treatments for pilonidal disease and compared outcomes of different approaches for treating colon cancer.
Is Dr. Erchinger's work relevant to obesity patients?
Yes, his research on bariatric surgery shows how significant weight loss can reduce the risk of developing polyps, which are linked to colorectal cancer.
What differences in cancer prognosis has Dr. Erchinger found?
He found that patients with medullary colon cancer tend to have worse survival rates compared to those with nonmedullary colon cancer.
Publications in plain English
Pilonidal disease of the anterior perineum: an unusual presentation and review of current practice guidelines.
2023
Wounds : a compendium of clinical research and practice
Matera D, Lushefski K, Erchinger T
Plain English This study looked at a rare case of pilonidal disease affecting the front part of the perineum instead of the more common area between the buttocks. A 20-year-old man underwent a specific surgery called the Bascom cleft lift to treat his recurring abscesses, and during the procedure, doctors found involvement of the anterior perineum, which they treated by simply removing hair in that area. This matters because it highlights that while effective surgical options exist for typical cases, more effective treatments for these rare cases still need to be established.
Who this helps: This helps patients with pilonidal disease and their doctors by providing insights into varied presentations of the condition.
Incidence of polyp formation following bariatric surgery.
2021
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Droney AC, Sellers W, Gupta A, Johnson KR, Fluck M +4 more
Plain English This study looked at how bariatric surgery affects the development of polyps, which can be precursors to colorectal cancer, in patients who are obese. Researchers found that patients who had surgery lost an average of 27.7% of their body weight, while those who used medical methods only lost 3.5%. Those with the most significant weight loss, especially from surgery, had a lower incidence of harmful polyps, indicating that losing weight can reduce cancer risk.
Who this helps: This benefits patients with obesity who are considering weight loss surgery as a way to improve their health and reduce cancer risk.
A Comparison of Treatments and Outcomes for Medullary versus Nonmedullary Colon Cancer: A Single Institutional Experience Showing a Worse Prognosis for Stage 3 Disease.
2020
Surgery research and practice
Gupta A, Protyniak B, Dove J, Chu K, Erchinger T +2 more
Plain English This study looked at two types of colon cancer: medullary colon cancer (MCC) and nonmedullary colon cancer (NMC), to see how treatment and survival outcomes differ between them at the Geisinger Health System. They found that patients with MCC had a median survival of 19.6 months, compared to 60.5 months for NMC patients. Specifically, stage 3 MCC patients had the worst outcomes, living only 9.6 months on average, which is much shorter than the 47.2 months for poorly differentiated or undifferentiated NMC patients.
Who this helps: This research helps doctors understand the treatment challenges and prognosis for patients with different types of colon cancer.
David Matera Kelcie Lushefski Andrew C Droney William Sellers Anjuli Gupta Kelly Rose Johnson Marcus Fluck Anthony Petrick Joseph Bannon Bogdan Protyniak
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.